return to web version
print this page
180 Attwell Drive, Suite 360
Toronto, ON, Canada
M9W 6A9
Tel: (416) 675-8280
Fax: (416) 675-8301
Email: ir@cangene.com
R. Craig Baxter — Board Chair and Director
Mr. Baxter graduated with a BComm from Concordia University and is a Certified Management Accountant. He has 30 years of business experience, 25 of which have been in the pharmaceutical industry. Currently, Mr. Baxter is President of Apotex Holdings Inc.
D. Bruce Burlington1,3 — Director and Human Resource & Compensation Committee Chair
Dr. Burlington received his medical degree from Louisiana State University. His extensive background in infectious disease medicine and the U.S. regulatory environment includes 17 years at the U.S. Food and Drug Administration in various positions involving both biologics and generic drugs, and nine years within the Wyeth Pharmaceuticals organization. He retired from his position as Executive Vice President, Business Practices and Compliance at Wyeth in 2007 and is currently working as a consultant in pharmaceutical development and regulatory affairs. Dr. Burlington is a member of the board of directors of AstraZeneca.
Jeremy Desai3 — Director
Dr. Desai graduated as a pharmacist in the U.K. and then went on to complete his PhD in Pharmacy and an MBA. Dr. Desai has 25 years of experience working for both branded and generic pharmaceutical companies. He is currently Executive Vice President Global Research, Development & Quality at Apotex Inc.; he joined the company in 2003. In 2009, Dr. Desai received the professional designation ICD.D from the Canadian Institute of Corporate Directors.
Philip Johnson2,3 — Director and Governance & Nominating Committee Chair
Dr. Johnson received his medical degree from the University of North Carolina at Chapel Hill. His extensive medical background, largely in pediatrics and vaccine technology, includes work at the U.S. National Institutes of Health and the Columbus Children’s Research Institute at Children’s Hospital, Inc. He is currently Chief Scientific Officer and Executive Vice President at The Children’s Hospital of Philadelphia and Professor of Pediatrics at the University of Pennsylvania School of Medicine.
Jack Kay1 — Director
Mr. Kay has 45 years’ experience in pharmaceutical management and sales, including 28 years with Apotex. He has academic training in business administration from the University of Manitoba and McGill University. Mr. Kay is President and COO of Apotex Inc., and serves on the board of Helix BioPharma Corp., a company listed on the Toronto and Frankfurt stock exchanges. He is a Past Chair of the Canadian Generic Pharmaceutical Association, the International Schizophrenia Foundation and the Humber River Regional Hospital in Toronto.
J. Robert Lavery1,2 — Director and Audit Committee Chair
Mr. Lavery, a Chartered Accountant, is President of Shaunnara ULC, an investment management company he has owned since forming the company in 1977. Until his retirement in 2003, Mr. Lavery was also President and CEO of Winpak Ltd., a position he held since co-founding the company in 1977. He continues as a member of the board of directors of Winpak Ltd. and all its subsidiary companies. Mr. Lavery is on the Advisory Council of Friesen Corporation, and has served on the boards of a number of community healthcare organizations. He has also received the professional designation ICD.D from the Canadian Institute of Corporate Directors.
R. Scott Lillibridge1,2 — Director
Dr. Lillibridge obtained his medical degree from the Uniformed Services University of the Health Sciences in Bethesda, MD. He has spent much of his public career with the U.S. Centers for Disease Control and Prevention (“CDC”). While at the CDC, he was the founding Director of the Bioterrorism Preparedness and Response Program and also served as Special Assistant to the Secretary for the Department of Health and Human Services. He is currently Assistant Dean and Professor of Epidemiology at the School of Rural Public Health and Clinical Professor at the College of Medicine at Texas A&M Health Science Center.
John Vivash2,3 — Director
Mr. Vivash is President and CEO of Tesseract Financial Inc., positions he has held since founding the financial services consultancy in 1989. Prior to that, he held various senior positions during his lengthy career in the investment community. He has also participated on committees for the Toronto, Montreal and Vancouver stock exchanges, and the Ontario Securities Commission. He has lectured extensively at the university level and at business and public conferences. He has also accumulated 25 years of board experience. He is on the board of directors of The Institute for Intellectual Capital Research and on the board of governors of OCAD University as well as being Chair of the OCAD University Foundation.
William Bees — Senior Vice President, Operations
Mr. Bees earned a BSc (Hons) in Microbiology and an MSc in Biochemistry from the University of Manitoba. He later earned an MBA from Athabasca University. He joined Rh Pharmaceuticals Inc. in 1981 and continued with Cangene after the companies amalgamated in 1995. Mr. Bees is the Treasurer of the Plasma Protein Therapeutics Association’s Source Board of Directors, and a member of the Parenteral Drug Association, the American Association of Blood Banks and the Associates within the Asper School of Business at the University of Manitoba.
Paul Brisebois — Vice President, Commercial Development
Mr. Brisebois holds a BComm from the University of Saskatchewan. He also graduated from Columbia University’s Executive Marketing Management Program, Wharton’s Competitive Marketing Strategy Program and the Queen’s University Executive Development Leadership Program. Before joining Cangene in 2009, he was Assistant Vice President, Marketing and Sales, at Richardson International Limited. Within the Richardson organization, Mr. Brisebois gained experience marketing both branded and commodity products. Prior to joining Richardson, he held various sales and marketing positions with Monsanto Canada’s Agricultural Products division.
Michael Graham — Acting President & CEO, CFO
Mr. Graham is a Chartered Accountant with a BComm in Accounting and Finance in addition to a BSc in Zoology/Genetics from the University of Manitoba. He has more than 25 years of senior management and finance experience with public and privately held corporations. Prior to joining Cangene in 2004, he was Chief Financial Officer of The Boyd Group Inc., the largest operator of collision repair centres in Canada and among the largest in North America. Prior to joining Boyd, he was Senior Vice President of Finance with Motor Coach Industries International, Inc.
Grant McClarty — Vice President, Research & Development
Dr. McClarty has a PhD in Microbiology from the University of Manitoba where he is currently a professor in the Department of Medical Microbiology and Infectious Diseases. Before joining Cangene in 2007, Dr. McClarty was Director of Biomedical Research at the National Microbiology Laboratory (“NML”), a division of the Public Health Agency of Canada, for six years. The NML is located in Winnipeg, Manitoba and is Canada’s leading public health infectious disease laboratory; it is responsible for the identification, control and prevention of infectious diseases.
Francis St. Hilaire — General Counsel & Secretary
Mr. St. Hilaire obtained a BSc degree from the University of Manitoba and then went on to obtain a Bachelor of Laws (magna cum laude) and an MBA from the University of Ottawa. Prior to joining Cangene in 2008, he was Assistant Vice President and Senior Counsel at The Great-West Life Assurance Company where he practised corporate and securities law. A member of the Manitoba Bar since 1992, he started his career practising general corporate and commercial law with the Winnipeg law firm of Aikins, MacAulay & Thorvaldson LLP.
Andrew Storey — Senior Vice President, Quality and Regulatory Affairs
Mr. Storey earned a BSc from the University of Manitoba. He has also obtained a Quality Assurance Management certificate from the University of Manitoba and a Chemical Technology diploma from New Brunswick College. He is a graduate of the Ivey Executive Program at the University of Western Ontario. Prior to joining Rh Pharmaceuticals Inc. in 1986, which amalgamated with Cangene in 1995, he worked in the environmental sciences field. Mr. Storey is a past President of the Health Care Products Association of Manitoba, and a member of the Drug Information Association, the Regulatory Affairs Professional Society, the Parenteral Drug Association and the American Association of Pharmaceutical Scientists.
ISO 9001- 2008 Certified